<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412018001000634</article-id>
<article-id pub-id-type="doi">10.24245/gom.v86i10.2167</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de infección de la vía urinaria y perfil microbiológico en mujeres que finalizaron el embarazo en una clínica privada de Lima, Perú]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence of urinary tract infection and microbiological profile in women who end their pregnancy in a private clinic in Lima, Peru]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quirós-Del Castillo]]></surname>
<given-names><![CDATA[Ana Lucía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Apolaya-Segura]]></surname>
<given-names><![CDATA[Moisés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad San Martín de Porres  ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad San Martín de Porres  ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Perú</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2018</year>
</pub-date>
<volume>86</volume>
<numero>10</numero>
<fpage>634</fpage>
<lpage>639</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412018001000634&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412018001000634&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412018001000634&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  Describir la prevalencia de infección de la vía urinaria en mujeres que finalizaron el embarazo en una clínica privada (nivel II-2) de Lima, Perú, además de conocer el perfil microbiológico e identificar la resistencia a los antibióticos.  Materiales y métodos:  Estudio retrospectivo, observacional y transversal efectuado en pacientes que finalizaron el embarazo en la Clínica Jesús del Norte del distrito de Independencia de Lima, Perú, entre enero de 2016 y diciembre del 2017. Criterio de inclusión: pacientes con al menos seis citas médicas de control prenatal en la clínica. Se obtuvo el resultado de los urocultivos y el de resistencia a los antibióticos. Se buscaron medidas de tendencia central como promedios, desviación estándar y frecuencias.  Resultados:  Se registraron 1455 pacientes que cumplieron con el criterio de inclusión; de éstas 108 (7.4%) tuvieron infección de la vía urinaria con urocultivo positivo. El microorganismo aislado con más frecuencia fue Escherichia coli en 70 (63.6%) casos, con resistencia a ampicilina (60.8%), ciprofloxacina (34.7%) y norfloxacina (34.7%), y sensibilidad a amikacina, nitrofurantoína y cefuroxima. En 13 (11.8%) pacientes también se identificó Escherichia coli y enterobacterias productoras de betalactamasas de espectro extendido resistentes a cefalosporinas.  Conclusión:  La prevalencia de infección de la vía urinaria estuvo dentro del valor de referencia expresado en los reportes internacionales (7.4%). Los microorganismos aislados con mayor frecuencia fueron E. coli y E. coli productora de betalactamasas de espectro extendido.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective:  To describe the prevalence of urinary tract infections (UTI) and their microbiological profile in pregnant women attended in a private clinic of level II-2 of Lima, Peru.  Materials and methods:  An analytical cross-sectional observational study was conducted, in women they had their delivery in a private clinic during January 2016 to December 2017. Inclusion criteria were those who had at least 06 prenatal care. Results of urocultures and their respective antibiotic resistance were obtained. In the statistical analysis, central tendency measures such as averages, standard deviation and frequencies were found.  Results:  1455 met the selection criteria. We found 108 patients (7.4%) with UTI with a positive urine culture. The 70 cases (63.6%) were Escherichia coli resistant to antibiotics such as: ampicillin (57.6%), ciprofloxacin (30.7%) and norfloxacin (30.7%), and sensitive to: amikacin, nitrofurantoin and cefuroxime. However, was is found that 13 (11.8%) had Escherichia coli BLEE resistant to cephalosporins.  Conclusion:  The prevalence of urinary infection was within what was expected in relation to international reports. The most commonly isolated uropathogen was Escherichia coli, followed by Escherichia coli BLEE.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Infección de la vía urinaria]]></kwd>
<kwd lng="es"><![CDATA[embarazo]]></kwd>
<kwd lng="es"><![CDATA[Perú]]></kwd>
<kwd lng="es"><![CDATA[resistencia antimicrobiana]]></kwd>
<kwd lng="es"><![CDATA[ampicilina]]></kwd>
<kwd lng="es"><![CDATA[ciprofloxacina]]></kwd>
<kwd lng="es"><![CDATA[norfloxacina]]></kwd>
<kwd lng="es"><![CDATA[amikacina]]></kwd>
<kwd lng="es"><![CDATA[nitrofurantoína]]></kwd>
<kwd lng="es"><![CDATA[cefuroxima]]></kwd>
<kwd lng="en"><![CDATA[Urinary tract infections]]></kwd>
<kwd lng="en"><![CDATA[Pregnant women]]></kwd>
<kwd lng="en"><![CDATA[Peru]]></kwd>
<kwd lng="en"><![CDATA[Antibiotic resistance]]></kwd>
<kwd lng="en"><![CDATA[Ampicillin]]></kwd>
<kwd lng="en"><![CDATA[Ciprofloxacin]]></kwd>
<kwd lng="en"><![CDATA[Norfloxacin]]></kwd>
<kwd lng="en"><![CDATA[Amikacin]]></kwd>
<kwd lng="en"><![CDATA[Nitrofurantoin]]></kwd>
<kwd lng="en"><![CDATA[Cefuroxime]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[FE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infección urinaria durante el embarazo, perfil de resistencia bacteriana al tratamiento en el Hospital General de Neiva, Colombia]]></article-title>
<source><![CDATA[Rev. Colomb. Obstet. Ginecol]]></source>
<year>2005</year>
<volume>56</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>239-43</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schnarr]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asymptomatic bacteriuria and symptomatic urinary tract infection in pregnancy]]></article-title>
<source><![CDATA[Eur J Clin Invest]]></source>
<year>2008</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Farkash]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2012</year>
<volume>162</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gravett]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serious and life-threatening pregnancyrelated infections: opportunities to reduce the global burden]]></article-title>
<source><![CDATA[PLoS Med]]></source>
<year></year>
<volume>9</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patterson]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
<name>
<surname><![CDATA[Andriole]]></surname>
<given-names><![CDATA[VT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era]]></article-title>
<source><![CDATA[Infect Dis Clin North Am]]></source>
<year>1997</year>
<numero>11</numero>
<issue>11</issue>
<page-range>593-608</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Geerlings]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical presentations and epidemiology of urinary tract infections]]></article-title>
<source><![CDATA[Microbiol Spectr]]></source>
<year>2016</year>
<volume>4</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asymptomatic bacteriuria in pregestational diabetic pregnancies and the role of group B streptococcus]]></article-title>
<source><![CDATA[Am J Perinatol]]></source>
<year>2010</year>
<volume>27</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>231-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Glaser]]></surname>
<given-names><![CDATA[AP1]]></given-names>
</name>
<name>
<surname><![CDATA[Schaeffer]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary tract infection and bacteriuria in pregnancy]]></article-title>
<source><![CDATA[Urol Clin N Am]]></source>
<year>2015</year>
<volume>42</volume>
<page-range>547-60</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sobel]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Kaye]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary tract infections]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Mandell]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dolin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Principles and practice of infectious diseases]]></source>
<year>2010</year>
<edition>7th</edition>
<page-range>957</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jeyabalan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anatomic and functional changes of the upper urinary tract during pregnancy]]></article-title>
<source><![CDATA[Urol Clin N Am]]></source>
<year>2007</year>
<volume>34</volume>
<page-range>16</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>Sociedad Espan&#771;ola de Ginecología y Obstetricia (SEGO)</collab>
<article-title xml:lang=""><![CDATA[Protocolo SEGO. Infección urinaria y gestación]]></article-title>
<source><![CDATA[Prog Obstet Ginecol]]></source>
<year>2013</year>
<volume>56</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>489-95</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jolley]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes]]></article-title>
<source><![CDATA[Drugs]]></source>
<year>2010</year>
<volume>70</volume>
<page-range>1643-55</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parveen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of urinary tract infection during pregnancy]]></article-title>
<source><![CDATA[J Dhaka National Med Coll Hos]]></source>
<year>2011</year>
<volume>17</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>8-12</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejos]]></surname>
<given-names><![CDATA[M C]]></given-names>
</name>
<name>
<surname><![CDATA[López-Villegas]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de infecciones de vías urinarias en embarazadas atendidas en el Hospital Universitario de Puebla]]></article-title>
<source><![CDATA[Enf Inf Microbiol]]></source>
<year>2010</year>
<volume>30</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>118-22</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ponce]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Características de la infección del tracto urinario recurrente en gestantes del Instituto Nacional Materno Perinatal 2007]]></source>
<year>2008</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Mayor de San Marcos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tapia-Maldonado]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
</person-group>
<source><![CDATA[Incidencia de infección del tracto urinario en gestantes asistentes al control materno del establecimiento de salud 1-3 José Antonio Encinas, Puno, Junio 2008 a Junio 2009]]></source>
<year>2009</year>
<publisher-name><![CDATA[Universidad Nacional del Altiplano]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rahman]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antimicrobial resistance pattern of gramnegative bacteria causing urinary tract infection]]></article-title>
<source><![CDATA[Stamford Journal of Pharmaceutical Sciences]]></source>
<year>2009</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>44-50</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Celen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asymptomatic bacteriuria and antibacterial susceptibility patterns in an obstetric population]]></article-title>
<source><![CDATA[Obstetrics and Gynecology]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendaciones para el diagnóstico microbiológico de la infección urinaria]]></article-title>
<source><![CDATA[Rev. Chil Infectol]]></source>
<year>2001</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>57-63</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abarzúa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reevaluación de la sensibilidad antimicrobiana de patógenos urinarios en el embarazo]]></article-title>
<source><![CDATA[Rev Chil Obstet Ginecol]]></source>
<year>2002</year>
<volume>67</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>226-31</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Autún Rosado]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Etiología y frecuencia de bacteriuria asintomática en mujeres embarazadas]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rizvi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: necessity for exploring newer treatment options]]></article-title>
<source><![CDATA[J Lab Physicians]]></source>
<year>2011</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>98-103</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casas]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de la resistencia a la ampicilina en gestantes con infección urinaria en el hospital universitario san José de Popayan (Colombia) 2007-2008]]></article-title>
<source><![CDATA[Rev Colomb Obstet Ginecol]]></source>
<year>2009</year>
<volume>60</volume>
<page-range>334-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Unlu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary tract infection in pregnant population, which empirical antimicrobial agent should be specified in each of the three trimesters?]]></article-title>
<source><![CDATA[Ginekol Pol]]></source>
<year>2014</year>
<volume>85</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>371-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
